3 active not recruiting, 1 completed. 2 Phase 1, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 2 |
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Unresectable Lung Small Cell Carcinoma: new trials by email Literature Review of Unresectable Lung Small Cell Carcinoma trials Research Report on Unresectable Lung Small Cell Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Supportive Care Intervention (ROAR-LCT) for Patients With Stage IIIA, IIIB, and IV Lung Cancer, ROAR-LCT Trial Best Practice, Exercise Intervention, Physical Therapy - Advanced Lung Non-Small Cell Carcinoma, Advanced Lung Small Cell Carcinoma | Not applicable | Completed | Ohio State University Comprehensive Cancer Center | 100 | 2022-04-14 | 2025-11-21 |
| Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic Cancer Biopsy Procedure, Biospecimen Collection, Computed Tomography - Metastatic Lung Small Cell Carcinoma, Metastatic Malignant Solid Neoplasm | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 29 | 2021-10-20 | 2026-09-10 |
| A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors 18F-Fluoromisonidazole, Cediranib Maleate, Laboratory Biomarker Analysis - Advanced Malignant Solid Neoplasm, Metastatic Lung Non-Small Cell Carcinoma | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 122 | 2016-08-31 | 2026-09-25 |
| M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery Berzosertib, Biopsy Specimen, Biospecimen Collection - Metastatic Colorectal Carcinoma, Metastatic Lung Small Cell Carcinoma | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 66 | 2016-07-22 | 2026-09-25 |
Lung Neoplasms (3) · Small Cell Lung Carcinoma (3) · Neoplasm Metastasis (2) · Pancreatic Neoplasms (2) · Breast Neoplasms (1) · Carcinoma, Neuroendocrine (1) · Carcinoma, Non-Small-Cell Lung (1) · Colorectal Neoplasms (1) · Triple Negative Breast Neoplasms (1)
Lung Diseases (4) · Neoplasms (4) · Neoplasms by Site (4) · Respiratory Tract Diseases (4) · Respiratory Tract Neoplasms (4) · Thoracic Neoplasms (4) · Bronchial Neoplasms (3) · Carcinoma, Bronchogenic (3) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Neoplastic Processes (2) · Pancreatic Diseases (2) · Pathologic Processes (2)
Irinotecan (2) · Magnetic Resonance Spectroscopy (2) · Specimen Handling (2) · BAY 1895344 (1) · Biopsy (1) · Physical Therapy Modalities (1) · Practice Guidelines as Topic (1) · Relaxation Therapy (1) · Standard of Care (1) · Topotecan (1) · berzosertib (1) · cediranib (1) · fluoromisonidazole (1) · olaparib (1)
National Cancer Institute (NCI) (3) · Ohio State University Comprehensive Cancer Center (1)
United States (4) · Canada (1)
Carolyn J Presley, MD (1) · Joseph W Kim (1) · Liza C Villaruz (1) · Thatcher Heumann (1)
UM1CA186689 (3), K76AG074923 (1), UM1CA186644 (1), UM1CA186690 (1), UM1CA186704 (1), UM1CA186717 (1)